Lindbrook Capital’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $13.3K | Sell |
440
-596
| -58% | -$18K | ﹤0.01% | 1535 |
|
|
2024
Q4 | $36.2K | Buy |
1,036
+671
| +184% | +$23.5K | ﹤0.01% | 952 |
|
|
2024
Q3 | $14.6K | Sell |
365
-24
| -6% | -$961 | ﹤0.01% | 1477 |
|
|
2024
Q2 | $18.5K | Buy |
389
+75
| +24% | +$3.58K | ﹤0.01% | 1287 |
|
|
2024
Q1 | $13.6K | Sell |
314
-79
| -20% | -$3.43K | ﹤0.01% | 1398 |
|
|
2023
Q4 | $19.9K | Buy |
393
+85
| +28% | +$4.3K | ﹤0.01% | 1179 |
|
|
2023
Q3 | $14K | Sell |
308
-38
| -11% | -$1.72K | ﹤0.01% | 1243 |
|
|
2023
Q2 | $14.2K | Buy |
346
+106
| +44% | +$4.35K | ﹤0.01% | 1265 |
|
|
2023
Q1 | $8.58K | Buy |
240
+125
| +109% | +$4.47K | ﹤0.01% | 1546 |
|
|
2022
Q4 | $4.34K | Sell |
115
-68
| -37% | -$2.57K | ﹤0.01% | 1893 |
|
|
2022
Q3 | $8K | Buy |
183
+126
| +221% | +$5.51K | ﹤0.01% | 1430 |
|
|
2022
Q2 | $2K | Hold |
57
| – | – | ﹤0.01% | 1978 |
|
|
2022
Q1 | $2K | Buy |
57
+37
| +185% | +$1.3K | ﹤0.01% | 2014 |
|
|
2021
Q4 | $1K | Sell |
20
-82
| -80% | -$4.1K | ﹤0.01% | 1937 |
|
|
2021
Q3 | $3K | Buy |
102
+86
| +538% | +$2.53K | ﹤0.01% | 1417 |
|
|
2021
Q2 | $1K | Sell |
16
-30
| -65% | -$1.88K | ﹤0.01% | 1776 |
|
|
2021
Q1 | $2K | Hold |
46
| – | – | ﹤0.01% | 1551 |
|
|
2020
Q4 | $3K | Buy |
+46
| New | +$3K | ﹤0.01% | 1340 |
|
|
2020
Q3 | – | Sell |
-20
| Closed | -$1K | – | 1793 |
|
|
2020
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 1571 |
|
|
2020
Q1 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 1477 |
|
|
2019
Q3 | – | Sell |
-44
| Closed | -$2K | – | 1474 |
|
|
2019
Q2 | $2K | Hold |
44
| – | – | ﹤0.01% | 1235 |
|
|
2019
Q1 | $3K | Hold |
44
| – | – | ﹤0.01% | 1161 |
|
|
2018
Q4 | $2K | Buy |
+44
| New | +$2K | ﹤0.01% | 1170 |
|